華髮股份(600325.SH):杭州鏵泓向杭州鏵璟增資17.55億元
格隆匯12月29日丨華髮股份(600325.SH)公佈,為推進公司紹興項目開發建設進度,公司全資子公司杭州鏵泓按持股比例(65%)向杭州鏵璟增資17.55億元;杭州鏵璟另一股東杭州招雅企業管理有限公司(以下簡稱“杭州招雅”)按持股比例(35%)向杭州鏵璟增資9.45億元。上述增資均以現金方式進行。增資完成後,杭州鏵璟股本變更為43億元,杭州鏵璟將向其全資子公司紹興鏵越置業有限公司(以下簡稱“紹興鏵越”)增資27億元。
本次增資系對公司控股子公司的增資,資金主要用於公司紹興項目的開發建設,以推進項目開發進度,加快項目週轉速度,提高經營效率。增資完成後,杭州鏵璟、紹興鏵越仍為公司的控股子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.